AN ADAPTIVE PHASE I/II DOSE ESCALATION TRIAL OF STEREOTACTIC BODY RADIATION THERAPY IN COMBINATION WITH RADIOMODULATING AGENT GC4419 IN LOCALLY ADVANCED PANCREATIC ADENOCARCINOMA
Clinical Trial Grant
Administered By
Radiation Oncology
Awarded By
Galera Therapeutics, Inc.
Start Date
September 5, 2019
End Date
August 31, 2021
Administered By
Radiation Oncology
Awarded By
Galera Therapeutics, Inc.
Start Date
September 5, 2019
End Date
August 31, 2021